About
Genis develops therapeutic chitin derivatives focused on treating inflammatory diseases and creating orthobiologic medical devices such as bone implants, leveraging over two decades of R&D in chitin biology.
Explore Genis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.